KIGABEQ

This brand name is authorized in Austria, Estonia, France, Ireland, Lithuania, Poland, United Kingdom

Active ingredients

The drug KIGABEQ contains one active pharmaceutical ingredient (API):

1 Vigabatrin
UNII GR120KRT6K - VIGABATRIN

Vigabatrin is a selective irreversible inhibitor of GABA transaminase, the enzyme responsible for the breakdown of GABA (gamma aminobutyric acid). Vigabatrin increases the concentration of GABA, the major inhibitory neurotransmitter in the brain.

Read about Vigabatrin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
KIGABEQ Soluble tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N03AG04 Vigabatrin N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AG Fatty acid derivatives
Discover more medicines within N03AG04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1780321, 1780332
Country: FR Base de données publique des médicaments Identifier(s): 62674714, 65022418
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 381094, 381097
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1086240, 1086241
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100411177, 100411183

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.